6 Ud af 339 nyretransplanterede patienter behandlet med basiliximab og testet for anti- idiotype antistoffer udviklede fire patienter (1, 2%) anti- idiotyp antistof- respons.
Immunogenicity Of 339 renal transplant patients treated with basiliximab and tested for anti-idiotype antibodies, 4 (1.2%) developed an anti-idiotype antibody response.